Christine Muench1, Corinde E Wiers2, Carlos R Cortes3, Reza Momenan3, Falk W Lohoff1. 1. Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland. 2. Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland. 3. Clinical NeuroImaging Research Core, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
Abstract
BACKGROUND: Alcohol's reinforcement is mediated by dopamine signaling in the ventral striatum, which is modulated by the dopamine transporter (DAT). We hypothesized that methylomic variation in the DAT gene (DAT1/SLC6A3) affects DAT expression, thus contributing to differences in brain reward circuitry in individuals with alcohol dependence (ALC). METHODS: Blood from 45 recently detoxified ALC and 45 healthy control (HC) individuals was used to assess DNA methylation across 5 functional regions of SLC6A3. Participants completed the monetary incentive delay task in a 3-Tesla magnetic resonance imaging (MRI) scanner. Employing regression models, we examined effects of SLC6A3 methylation on nucleus accumbens (NAc) blood-oxygen-level dependent (BOLD) responses during anticipation of high/low reward/loss. RESULTS: Results showed that decreased methylation of the promoter region of SLC6A3 predicted NAc activation during high loss anticipation (p = 0.028) and low loss anticipation (at trend-level; p = 0.057) in HC but not in individuals with ALC. Specifically, percentage of methylation at 2 CpG sites, located -1,001 and -993 base pairs from the transcription start site, accounted for significant variability in NAc activation in the HC group during high (ps ≤ 0.010) and low (ps ≤ 0.006) loss anticipation. There was no effect on reward anticipation. Furthermore, promoter methylation was positively associated with age, which replicates previous findings. CONCLUSIONS: Our data suggest that methylation in the promoter region of SLC6A3 predicts NAc activation during the anticipation of monetary loss in HCs. However, this effect was not present in the ALC group, suggesting that epigenetic regulation of striatal DAT expression might be disrupted in ALC, which may contribute to previously reported differences in sensitivity to reward and punishment in this population. Alternatively, it is possible that a similar relationship in the ALC group remained undetected possibly due to methodological limitations inherent in functional MRI (e.g., poor spatial resolution, low signal-to-noise ratio) that generally restrict interpretations regarding mechanisms of epigenetic factors involved in group differences in BOLD responses. Future neuroimaging studies are needed to further elucidate the relationship between SLC6A3 methylation and NAc activation in ALC. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND:Alcohol's reinforcement is mediated by dopamine signaling in the ventral striatum, which is modulated by the dopamine transporter (DAT). We hypothesized that methylomic variation in the DAT gene (DAT1/SLC6A3) affects DAT expression, thus contributing to differences in brain reward circuitry in individuals with alcohol dependence (ALC). METHODS: Blood from 45 recently detoxified ALC and 45 healthy control (HC) individuals was used to assess DNA methylation across 5 functional regions of SLC6A3. Participants completed the monetary incentive delay task in a 3-Tesla magnetic resonance imaging (MRI) scanner. Employing regression models, we examined effects of SLC6A3 methylation on nucleus accumbens (NAc) blood-oxygen-level dependent (BOLD) responses during anticipation of high/low reward/loss. RESULTS: Results showed that decreased methylation of the promoter region of SLC6A3 predicted NAc activation during high loss anticipation (p = 0.028) and low loss anticipation (at trend-level; p = 0.057) in HC but not in individuals with ALC. Specifically, percentage of methylation at 2 CpG sites, located -1,001 and -993 base pairs from the transcription start site, accounted for significant variability in NAc activation in the HC group during high (ps ≤ 0.010) and low (ps ≤ 0.006) loss anticipation. There was no effect on reward anticipation. Furthermore, promoter methylation was positively associated with age, which replicates previous findings. CONCLUSIONS: Our data suggest that methylation in the promoter region of SLC6A3 predicts NAc activation during the anticipation of monetary loss in HCs. However, this effect was not present in the ALC group, suggesting that epigenetic regulation of striatal DAT expression might be disrupted in ALC, which may contribute to previously reported differences in sensitivity to reward and punishment in this population. Alternatively, it is possible that a similar relationship in the ALC group remained undetected possibly due to methodological limitations inherent in functional MRI (e.g., poor spatial resolution, low signal-to-noise ratio) that generally restrict interpretations regarding mechanisms of epigenetic factors involved in group differences in BOLD responses. Future neuroimaging studies are needed to further elucidate the relationship between SLC6A3 methylation and NAc activation in ALC. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Falk W Lohoff; Paul J Bloch; Rachel Hodge; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Charles A Dackis; Charles P O'Brien; Helen M Pettinati; David W Oslin Journal: Neurosci Lett Date: 2010-02-17 Impact factor: 3.046
Authors: Catrin Wernicke; Michael Smolka; Jürgen Gallinat; Georg Winterer; Lutz G Schmidt; Hans Rommelspacher Journal: Neurosci Lett Date: 2002-11-15 Impact factor: 3.046
Authors: Jean-Claude Dreher; Philip Kohn; Bhaskar Kolachana; Daniel R Weinberger; Karen Faith Berman Journal: Proc Natl Acad Sci U S A Date: 2008-12-22 Impact factor: 11.205
Authors: Pitna Kim; Chang Soon Choi; Jin Hee Park; So Hyun Joo; Soo Young Kim; Hyun Myung Ko; Ki Chan Kim; Se Jin Jeon; Seung Hwa Park; Seol-Heui Han; Jong Hoon Ryu; Jae Hoon Cheong; Jung Yeol Han; Ki Narm Ko; Chan Young Shin Journal: J Neurosci Res Date: 2014-02-07 Impact factor: 4.164
Authors: Yuliya S Nikolova; Karestan C Koenen; Sandro Galea; Chiou-Miin Wang; Marianne L Seney; Etienne Sibille; Douglas E Williamson; Ahmad R Hariri Journal: Nat Neurosci Date: 2014-08-03 Impact factor: 24.884
Authors: Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow Journal: Eur J Neurosci Date: 2018-08 Impact factor: 3.386
Authors: Anna Grzywacz; Wojciech Barczak; Jolanta Chmielowiec; Krzysztof Chmielowiec; Aleksandra Suchanecka; Grzegorz Trybek; Jolanta Masiak; Paweł Jagielski; Katarzyna Grocholewicz; Blazej Rubiś Journal: Brain Sci Date: 2020-06-23
Authors: Kyoungjune Pak; Ju Won Seok; Hyun-Yeol Nam; Seongho Seo; Myung Jun Lee; Keunyoung Kim; In Joo Kim Journal: EJNMMI Res Date: 2021-06-12 Impact factor: 3.138
Authors: Emily N W Wheater; David Q Stoye; Simon R Cox; Joanna M Wardlaw; Amanda J Drake; Mark E Bastin; James P Boardman Journal: Neurosci Biobehav Rev Date: 2020-03-06 Impact factor: 8.989
Authors: Damian Czarnecki; Marcin Ziółkowski; Jan Chodkiewicz; Anna Długosz; Joanna Feldheim; Napoleon Waszkiewicz; Agnieszka Kułak-Bejda; Marta Gorzkiewicz; Jacek Budzyński; Anna Junkiert-Czarnecka; Agnieszka Siomek-Górecka; Krzysztof Nicpoń; Aleksandra Kawala-Sterniuk; Raffaele Ferri; Mariusz Pelc; Piotr Walecki; Ewa Laskowska; Edward Jacek Gorzelańczyk Journal: J Clin Med Date: 2021-12-15 Impact factor: 4.241